Letter to the Editor. Supratotal resection of glioblastoma

Restricted access

Article Information

Correspondence Fatih Incekara: f.incekara@erasmusmc.nl.

INCLUDE WHEN CITING Published online August 16, 2019; DOI: 10.3171/2019.3.JNS19810.

Disclosures The authors report no conflict of interest.

© AANS, except where prohibited by US copyright law.

Headings

References

  • 1

    Aldave GTejada SPay EMarigil MBejarano BIdoate MA: Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic acid-guided surgery. Neurosurgery 72:9159212013

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Eidel OBurth SNeumann JOKieslich PJSahm FJungk C: Tumor infiltration in enhancing and non-enhancing parts of glioblastoma: a correlation with histopathology. PLoS One 12:e01692922017

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    Esquenazi YFriedman ELiu ZZhu JJHsu STandon N: The survival advantage of “supratotal” resection of glioblastoma using selective cortical mapping and the subpial technique. Neurosurgery 81:2752882017 (Errata in Neurosurgery 81:404 2017; Neurosurgery 81:1047 2017)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Eyüpoglu IYHore NMerkel ABuslei RBuchfelder MSavaskan N: Supra-complete surgery via dual intraoperative visualization approach (DiVA) prolongs patient survival in glioblastoma. Oncotarget 7:25755257682016

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Glenn CABaker CMConner AKBurks JDBonney PABriggs RG: An examination of the role of supramaximal resection of temporal lobe glioblastoma multiforme. World Neurosurg 114:e747e7552018

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6

    Kotrotsou AElakkad ASun JThomas GAYang DAbrol S: Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome. J Neurooncol 139:1251332018

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Li YMSuki DHess KSawaya R: The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection? J Neurosurg 124:9779882016

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    Pessina FNavarria PCozzi LAscolese AMSimonelli MSantoro A: Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience. J Neurooncol 135:1291392017

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9

    Roh THKang SGMoon JHSung KSPark HHKim SH: Survival benefit of lobectomy over gross-total resection without lobectomy in cases of glioblastoma in the noneloquent area: a retrospective study. J Neurosurg [epub ahead of print March 1 2019. DOI: 10.3171/2018.12.JNS182558]

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Stummer WPichlmeier UMeinel TWiestler ODZanella FReulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:3924012006

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Taphoorn MJStupp RCoens COsoba DKortmann Rvan den Bent MJ: Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol 6:9379442005

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 149 149 129
Full Text Views 37 37 35
PDF Downloads 13 13 12
EPUB Downloads 0 0 0

PubMed

Google Scholar